NATCOPHARM.BONATCOPHARM.BOBSE
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+63.0%
5Y CAGR+27.9%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+63.0%/yr
vs -14.0%/yr prior
5Y CAGR
+27.9%/yr
Recent acceleration
Acceleration
+77.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.4x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $30.00B | +15.6% |
| 2024 | $25.96B | +74.1% |
| 2023 | $14.92B | +115.2% |
| 2022 | $6.93B | -25.6% |
| 2021 | $9.31B | +6.1% |
| 2020 | $8.77B | -18.7% |
| 2019 | $10.79B | -14.7% |
| 2018 | $12.65B | +22.9% |
| 2017 | $10.29B | +90.2% |
| 2016 | $5.41B | - |